| Placebo (N = 28) | Supplement (N = 30) | p |
---|---|---|---|
Age (years) | 32.9 ± 5.6 | 34.9 ± 5.8 | 0.2 |
Gender, (%male) | 64.3 | 73.3 | 0.5 |
Body mass index (kg/m2) | 26.6 ± 2.9 | 26.0 ± 1.9 | 0.6 |
Current smokers (%) | 75.0 | 53.3 | 0.1 |
Systolic blood pressure (mm Hg) | 126.9 ± 10.2 | 122.7 ± 10.4 | 0.08 |
Diastolic blood pressure (mm Hg) | 78.5 ± 8.8 | 74.4 ± 8.5 | 0.1 |
WBC (103/μL) | 5.7 ± 1.4 | 6.24 ± 1.3 | 0.2 |
RBC (106/μL | 4.4 ± 1.4 | 4.54 ± 1.3 | 0.7 |
PLT 103/μL | 224.0 ± 59.1 | 240.64 ± 32.4 | 0.2 |
Hb (g/L) | 14.6 ± 2.7 | 15.14 ± 1.3 | 0.5 |
Ht (%) | 40.9 ± 4.2 | 40.34 ± 4.0 | 0.5 |
Glucose (mmol/L) | 5.31 ± 0.56 | 5.62 ± 0.71 | 0.08 |
Cholesterol (mmol/L) | 4.85 ± 1.11 | 5.20 ± 1.09 | 0.2 |
HDL-cholesterol (mmol/L) | 1.27 ± 0.36 | 1.19 ± 0.4 | 0.4 |
LDL-cholesterol (mmol/L) | 3.20 ± 1.13 | 3.57 ± 1.13 | 0.2 |
Triacylglycerols (mmol/L) | 0.82 ± 0.44 | 1.04 ± 0.73 | 0.2 |
Uric acid (mmol/L) | 0.28 ± 0.07 | 0.27 ± 0.07 | 0.6 |